BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18443575)

  • 1. Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.
    Fujii H; Takiuchi S; Kawano Y; Fukagawa M
    Am J Hypertens; 2008 Jun; 21(6):650-6. PubMed ID: 18443575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
    Ronden RA; Houben AJ; Teerlink T; Bakker JA; Bierau J; Stehouwer CD; De Leeuw PW; Kroon AA
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F149-56. PubMed ID: 22552932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
    Takiuchi S; Fujii H; Kamide K; Horio T; Nakatani S; Hiuge A; Rakugi H; Ogihara T; Kawano Y
    Am J Hypertens; 2004 Sep; 17(9):802-8. PubMed ID: 15363823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study.
    Fliser D; Kronenberg F; Kielstein JT; Morath C; Bode-Böger SM; Haller H; Ritz E
    J Am Soc Nephrol; 2005 Aug; 16(8):2456-61. PubMed ID: 15930091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.
    Ivanova M; Artusi C; Boffa GM; Zaninotto M; Plebani M
    Clin Chim Acta; 2010 Nov; 411(21-22):1632-6. PubMed ID: 20542018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.
    Kielstein JT; Böger RH; Bode-Böger SM; Frölich JC; Haller H; Ritz E; Fliser D
    J Am Soc Nephrol; 2002 Jan; 13(1):170-176. PubMed ID: 11752034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between brachial-ankle pulse wave velocity and the ratio of l-arginine to asymmetric dimethylarginine in patients undergoing coronary angiography.
    Masaki N; Hakuno D; Toya T; Shiraishi Y; Kujiraoka T; Namba T; Yada H; Kimura K; Miyazaki K; Adachi T
    J Cardiol; 2015 Apr; 65(4):311-7. PubMed ID: 25043133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.
    Marrocos MS; Teixeira AA; Quinto BM; Carmona Sde M; Kuniyoshi M; Rodrigues CJ; Dalboni MA; Manfredi S; Canziani ME; Batista MC
    Lipids Health Dis; 2016 Jan; 15():14. PubMed ID: 26790728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
    Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
    Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus.
    Kawata T; Daimon M; Hasegawa R; Teramoto K; Toyoda T; Sekine T; Yamamoto K; Uchida D; Himi T; Yoshida K; Komuro I
    Int J Cardiol; 2009 Feb; 132(2):286-8. PubMed ID: 18083252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of assessing coronary flow velocity reserve and plasma endothelin-1 in hypertensive patients.
    Fujii H; Takiuchi S; Kamide K; Horio T; Niizuma S; Tanaka N; Hashimoto S; Nakatani S; Fukagawa M; Kawano Y
    Hypertens Res; 2005 Nov; 28(11):911-6. PubMed ID: 16555580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.
    Wang J; Sim AS; Wang XL; Salonikas C; Moriatis M; Naidoo D; Wilcken DE
    Atherosclerosis; 2008 Apr; 197(2):853-9. PubMed ID: 17826782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerobic exercise training decreases plasma asymmetric dimethylarginine concentrations with increase in arterial compliance in postmenopausal women.
    Tanahashi K; Akazawa N; Miyaki A; Choi Y; Ra SG; Matsubara T; Kumagai H; Oikawa S; Maeda S
    Am J Hypertens; 2014 Mar; 27(3):415-21. PubMed ID: 24280041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects.
    Kielstein JT; Bode-Böger SM; Frölich JC; Ritz E; Haller H; Fliser D
    Circulation; 2003 Apr; 107(14):1891-5. PubMed ID: 12681993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of large arteries in hypertension in relation to oxidative stress markers.
    Klima Ł; Kawecka-Jaszcz K; Stolarz-Skrzypek K; Menne J; Fijorek K; Olszanecka A; Wojciechowska W; Bilo G; Czarnecka D
    Kardiol Pol; 2013; 71(9):917-23. PubMed ID: 24065420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between asymmetric dimethylarginine plasma level and left ventricular mass in hemodialysis patients.
    El Shahawy Y; Soliman Y; Rifaie A; Shenawy H; Behairy M; Mady G
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):26-33. PubMed ID: 25579712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between estimated glomerular filtration rate (eGFR) and asymmetric dimethylarginine (ADMA) concentrations among the elderly in a rural community: a cross-sectional study.
    Choi HR; Lee SW; Jeon DH; Hur NW; Youm Y; Kim HC
    BMC Geriatr; 2019 Dec; 19(1):370. PubMed ID: 31870320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.